Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Alzheimer's disease Stories

Gene Variation In Mild Cognitive Impairment Associated With Brain Atrophy
2014-01-14 10:09:03

Radiological Society of North America The presence of a gene variant in people with mild cognitive impairment (MCI) is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology. The study focused on the gene apolipoprotein E (APOE), the most important genetic factor known in non-familial Alzheimer's disease (AD). APOE has different alleles, or gene variations, said the study's senior author, Jeffrey R. Petrella, M.D.,...

2014-01-14 08:29:52

PLANTATION, Fla., Jan. 14, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that Dr. James New, the Company's President and Chief Executive Officer, will present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 11:00AM Eastern Time on Tuesday, January 21, 2014 at the Club Med Resort in Sandpiper Bay, Florida. The Company will discuss its unique position as it works towards commercializing certain technologies that were...

2014-01-13 23:00:24

The presence of a gene variant in people with mild cognitive impairment (MCI) is associated with accelerated rates of brain atrophy, according to a new study published online, January 14, in the journal Radiology. Oak Brook, Ill. (PRWEB) January 13, 2014 The presence of a gene variant in people with mild cognitive impairment (MCI) is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology. The study focused on the gene...

SAGE Test Helps Spot Early Alzheimer's
2014-01-13 10:54:07

[ Watch The Video: Self-Administered Test Helps Spot Early Alzheimer’s ] The Ohio State University Wexner Medical Center The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes to complete, is a reliable tool for evaluating cognitive abilities. Findings by researchers at The Ohio State University Wexner Medical Center confirming the feasibility and efficiency of the tool for community screening large numbers of people are published in the...

2014-01-13 10:21:10

New Study Pinpoints Structural Effects of V44M and V44A Mutations New research, led by Rensselaer Polytechnic Institute researcher Chunyu Wang, has solved one mystery in the development of Familial Alzheimer’s Disease (FAD), a genetic variant of the disease that affects a small fraction of the Alzheimer’s population. In a paper published January 6 in the journal Nature Communications, Wang and his team follow the trail of two genetic mutations – V44M and V44A – known to cause FAD,...

2014-01-11 23:00:10

Business owner and author, Gina Wilson, shares her balance of Alzheimer’s caregiving and professional life. Las Vegas, NV (PRWEB) January 12, 2014 Caregiving While Managing Business and Home Life Business Owner Shares Her Balance of Alzheimer’s Caregiving and Professional Life Alzheimer’s is the sixth leading cause of death in the U.S. and given the 68 percent increase between 2000 and 2010, it is quickly becoming an epidemic. Author Gina Wilson is no stranger to the disease after...

2014-01-09 08:28:50

EMERYVILLE, Calif., Jan. 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. announced today that it has received $40 million in milestone payments from Forest Laboratories Holdings Limited (NYSE: FRX) for MDX-8704. MDX-8704 is a fixed dosed combination (FDC) of Namenda XR(®) (memantine HCl extended release capsules) and donepezil HCl being developed as a once daily therapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the United States. The...

2014-01-09 08:28:04

BOSTON, Jan. 9, 2014 /PRNewswire/ -- Akili Interactive Labs Inc. ("Akili") announced today that it has entered into an agreement with Pfizer Inc. to test the ability of Akili's mobile video game platform ("Project EVO") to detect cognitive differences in healthy elderly people at risk of developing Alzheimer's disease. To Akili's knowledge this is the first time that a large pharmaceutical company will test the use of a mobile video game as a clinical tool to determine early signs of...

2014-01-08 23:01:25

Stem cell research funded in part by the Cure Alzheimer's Fund allows scientists to identify new gene targets in patients suffering from the disease. New York, NY (PRWEB) January 08, 2014 A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was...

2014-01-07 00:20:23

Early diagnosis keeps lives from unravelling says Alzheimer Society during Alzheimer Awareness Month TORONTO, Jan. 7, 2014 /CNW/ - As many as 50 per cent of Canadians with dementia are not diagnosed early enough,* losing precious time when care and support can make a tremendous difference in their quality of life and avert unnecessary crises for their families. That's why during Alzheimer Awareness Month, the Alzheimer Society is launching a new campaign, Early diagnosis keeps...